nasal semaglutide A Chinese biotech firm is reportedly racing to turn Wegovy's blockbuster weight-loss molecule into a cheaper, needle‑free spray, with global trials slated for completion by 2028. Shanghai Shiling Pharmaceutical is developing Semaglutide Nasal Spray Approved for

These unlawful marketing and sales practices, including the use of Novo Nordisk trademarks in connection with these practices, have created a high risk of consumer confusion and deception as well as potential safety concerns, the release continues

In a previous piece covering semaglutide and other GLP-1 medication, we discussed some of the ways that employers are adapting in order to offer these drug treatments to employees without exposing the health plan to out-of-control costs, including implementing lifetime caps, minimum BMI caps, and limiting access to cheaper GLP-1 options: Lifetime Cap : Some employers are limiting their exposure to excessive GLP-1 weight loss expenses by setting a lifetime cap on the amount of funds available to covered employees

Keep at least an inch between injection sites

Thats a disruption that a fuller medication menu prevents

everydayhealth.com Glossary GLP-1: Glucagon-like peptide-1, a gut hormone that helps control appetite and blood sugar